A systematic review of the quality of liver biopsy specimens

被引:192
作者
Cholongitas, E
Senzolo, M
Standish, R
Marelli, L
Quaglia, A
Patch, D
Dhillon, AP
Burroughs, AK
机构
[1] Royal Free Hosp, Liver Transplantat & Hepatobiliary Med, London NW3 2QG, England
[2] Royal Free Hosp, Dept Histopathol, London NW3 2QG, England
关键词
liver biopsy; percutaneous liver biopsy; transjugular liver biopsy; length; portal tract;
D O I
10.1309/W3XCNT4HKFBN2G0B
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Characteristics for an optimal liver biopsy specimen, were recently defined as 20 to 25 mm long and/or containing more than 11 complete portal tracts (CPTs). A systematic review of percutaneous liver biopsy (PLB) and transjugular liver biopsy (TJLB) series yielded only 32 PLB studies in which these characteristics were evaluated: mean +/- SD length, 17.7 +/- 5.8 mm and number of CPTs, 7.5 +/- 3.4; and 15 TJLB studies: mean. SD length, 13.5 +/- 4.5 mm and number of CPTs, 6.8 +/- 2.3. Studies of sampling heterogeneity and intraobserver and interobserver variability also used inadequate specimens by present standards. Only 11 (5.3%) of 207 therapeutic studies for chronic hepatitis B and C documented length and/or number of CPTs. Of the current 12 studies evaluating noninvasive fibrosis tests, only 8 documented length or number of CPTs, and only 1 documented length. and number of CPTs. New studies are needed based on adequate liver biopsy samples to provide reliable estimation of grading and staging in chronic liver disease.
引用
收藏
页码:710 / 721
页数:12
相关论文
共 127 条
[91]   Feasibility of histological grading and staging of chronic viral hepatitis using specimens obtained by thin-needle biopsy [J].
Petz, D ;
Klauck, S ;
Röhl, FW ;
Malfertheiner, P ;
Roessner, A ;
Röcken, C .
VIRCHOWS ARCHIV, 2003, 442 (03) :238-244
[92]   COMPLICATIONS FOLLOWING PERCUTANEOUS LIVER-BIOPSY - A MULTICENTER RETROSPECTIVE STUDY ON 68 276 BIOPSIES [J].
PICCININO, F ;
SAGNELLI, E ;
PASQUALE, G ;
GIUSTI, G .
JOURNAL OF HEPATOLOGY, 1986, 2 (02) :165-173
[93]   Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection [J].
Poynard, T ;
Zoulim, F ;
Ratziu, V ;
Degos, F ;
Imbert-Bismut, F ;
Deny, P ;
Landais, P ;
El Hasnaoui, A ;
Slama, A ;
Blin, P ;
Thibault, V ;
Parvaz, P ;
Munteanu, M ;
Trepo, C .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09) :1970-1980
[94]   Viral hepatitis C [J].
Poynard, T ;
Yuen, MF ;
Ratziu, V ;
Lai, CL .
LANCET, 2003, 362 (9401) :2095-2100
[95]   Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin [J].
Poynard, T ;
McHutchison, J ;
Manns, M ;
Myers, RP ;
Albrecht, J .
HEPATOLOGY, 2003, 38 (02) :481-492
[96]   Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial [J].
Poynard, T ;
Marcellin, P ;
Bissery, A ;
Myers, RP ;
Moussalli, J ;
Degos, F ;
Dhumeaux, D ;
Riachi, G ;
Bronowicki, JP ;
Brissot, P ;
Buffet, C ;
Serfaty, L ;
Naveau, S ;
Sogni, P ;
Beaugrand, M ;
Gayno, S ;
Larrey, D ;
Samuel, D ;
Eugene, C ;
Pol, S ;
Bedossa, P ;
Daurat, V ;
Chaumet-Riffaud, P .
JOURNAL OF VIRAL HEPATITIS, 2003, 10 (03) :197-204
[97]   Predictive value of ALT levels for histologic findings in chronic hepatitis C:: A European collaborative study [J].
Pradat, P ;
Alberti, A ;
Poynard, T ;
Esteban, JI ;
Weiland, O ;
Marcellin, P ;
Badalamenti, S ;
Trépo, C .
HEPATOLOGY, 2002, 36 (04) :973-977
[98]  
Regan J, 1997, HEPATOLOGY, V26, P611
[99]  
Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x
[100]  
Robles-Diaz G, 1985, Rev Gastroenterol Mex, V50, P13